Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study
published in: Alimentary Pharmacology & Therapeutics
date of publication: 2020-09-09
main subject: inflammatory bowel diseases
Cites articles
There is nothing here
Article - wd:Q99235553